BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37139340)

  • 1. Association of circulating omentin level and metabolic-associated fatty liver disease: a systematic review and meta-analysis.
    Zhang Q; Chen S; Ke Y; Li Q; Shen C; Ruan Y; Wu K; Hu J; Liu S
    Front Endocrinol (Lausanne); 2023; 14():1073498. PubMed ID: 37139340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating chemerin levels in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
    Ren Q; Wang H; Zeng Y; Fang X; Wang M; Li D; Huang W; Xu Y
    Lipids Health Dis; 2022 Mar; 21(1):27. PubMed ID: 35236351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
    Ke Y; Liu S; Zhang Z; Hu J
    Lipids Health Dis; 2021 May; 20(1):55. PubMed ID: 34034750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and meta-analysis of cohort studies on the potential association between NAFLD/MAFLD and risk of incident atrial fibrillation.
    Zhou BG; Ju SY; Mei YZ; Jiang X; Wang M; Zheng AJ; Ding YB
    Front Endocrinol (Lausanne); 2023; 14():1160532. PubMed ID: 37476492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lifestyle intervention on adults with metabolic associated fatty liver disease: A systematic review and meta-analysis.
    Chai XN; Zhou BQ; Ning N; Pan T; Xu F; He SH; Chen NN; Sun M
    Front Endocrinol (Lausanne); 2023; 14():1081096. PubMed ID: 36875459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association between Circulating Adipocytokine Omentin Levels and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Khodashahi R; Aliakbarian M; Ferns GA; Arjmand MH
    Curr Mol Med; 2023 Sep; ():. PubMed ID: 37711002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between omentin and obstructive sleep apnea: A meta-analysis.
    She N; Liu N; Ren X; Liu H
    Clin Respir J; 2023 Mar; 17(3):139-147. PubMed ID: 36719004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of circulating vaspin levels and patients with metabolic-associated fatty liver disease: a systematic review and meta-analysis.
    Zhu Y; Ke Y; Hu Y; Wu K; Liu S; Hu J
    Lipids Health Dis; 2022 Jul; 21(1):57. PubMed ID: 35780150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of circulating omentin levels in various malignant tumors: Evidence from a systematic review and meta-analysis.
    Arjmand MH; Moradi A; Akbari A; Mehrad-Majd H
    Cytokine; 2020 Jan; 125():154869. PubMed ID: 31585311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis.
    Jagirdhar GSK; Qasba RK; Pattnaik H; Rama K; Banga A; Reddy ST; Flumignan Bucharles AC; Kashyap R; Elmati PR; Bansal V; Bains Y; DaCosta T; Surani S
    World J Gastroenterol; 2023 Jun; 29(21):3362-3378. PubMed ID: 37377589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Polyzos SA; Aronis KN; Kountouras J; Raptis DD; Vasiloglou MF; Mantzoros CS
    Diabetologia; 2016 Jan; 59(1):30-43. PubMed ID: 26407715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Non-Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver Disease with COVID-19-Related Intensive Care Unit Outcomes: A Systematic Review and Meta-Analysis.
    Jagirdhar GSK; Pattnaik H; Banga A; Qasba RK; Rama K; Reddy ST; Bucharles ACF; Kashyap R; Elmati PR; Bansal V; Bains Y; DaCosta T; Surani S
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512051
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulating apelin, chemerin and omentin levels in patients with gestational diabetes mellitus: a systematic review and meta-analysis.
    Sun J; Ren J; Zuo C; Deng D; Pan F; Chen R; Zhu J; Chen C; Ye S
    Lipids Health Dis; 2020 Feb; 19(1):26. PubMed ID: 32087711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between adipocytokines and diabetic retinopathy: a systematic review and meta-analysis.
    Jiang Y; Fan H; Xie J; Xu Y; Sun X
    Front Endocrinol (Lausanne); 2023; 14():1271027. PubMed ID: 37867518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: A systematic review and meta-analysis.
    Agustanti N; Soetedjo NNM; Damara FA; Iryaningrum MR; Permana H; Bestari MB; Supriyadi R
    Diabetes Metab Syndr; 2023 May; 17(5):102780. PubMed ID: 37201293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short sleep duration and the risk of nonalcoholic fatty liver disease/metabolic associated fatty liver disease: a systematic review and meta-analysis.
    Yang J; Zhang K; Xi Z; Ma Y; Shao C; Wang W; Tang YD
    Sleep Breath; 2023 Oct; 27(5):1985-1996. PubMed ID: 36544011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating omentin-1 levels in women with polycystic ovary syndrome: a meta-analysis.
    Tang YL; Yu J; Zeng ZG; Liu Y; Liu JY; Xu JX
    Gynecol Endocrinol; 2017 Mar; 33(3):244-249. PubMed ID: 27908216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Diagnostic and Prognostic Value of the Triglyceride-Glucose Index in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Systematic Review and Meta-Analysis.
    Wang J; Yan S; Cui Y; Chen F; Piao M; Cui W
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36500999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic-associated fatty liver disease and risk of esophagogastric cancer: a systematic review and meta-analysis.
    Zou Q; Tan HY; Li JC; Li YD; Yang K
    Jpn J Clin Oncol; 2023 Jul; 53(8):680-690. PubMed ID: 37132637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.